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IncA variation among Dutch Chlamydia trachomatis isolates was investigated. Of 98 strains, two carried an
incA with a premature stop codon, lacked IncA, and were nonfusogenic, while 96 contained an intact incA,
expressed IncA, and were fusogenic. Among these 96 strains, nine IncA sequence types were found, of which the
three most frequently encountered (88% of the strains) were randomly distributed among symptomatic and
asymptomatic patients.
Chlamydia trachomatis is an obligate intracellular pathogen,
responsible for sexually transmitted disease (STD) (4, 6). The
bacteria replicate intracellularly in a membrane-bound vacuole
(inclusion) that is modified through the insertion of chlamydial
proteins, collectively classified as Inc proteins, including IncA
(5, 11). Inc proteins are generally characterized by a typical
bi-lobed hydrophobic domain of approximately 60 amino acids
but lack overall amino acid homology (1). Strains with muta-
tions in incA, resulting into a premature stop codon, reside in
multiple small homotypic inclusions that, in contrast to inclu-
sions containing wild-type incA strains, do not fuse with each
other (12). This strongly suggests involvement of IncA in the
homotypic fusion of the inclusions. It has been previously
shown from the study of 11,440 isolates that only 176 (1.5%)
had the nonfusogenic phenotype (16). The observation that the
nonfusogenic strains are identified among patients with less-
severe disease symptoms suggests that incA polymorphisms
may be involved in the clinical course of the infection (3).
We have previously reported the incA sequence polymor-
phisms and fusogenic properties of 25 C. trachomatis labora-
tory reference strains comprising most serovars (9). Among
these laboratory strains, all of which contained an incA gene
encoding a full-length 273-amino-acid-long protein, 12 IncA
amino acid sequence types (STs) were identified. In addition,
these strains were fusogenic and expressed IncA in the inclu-
sion membrane (IM), irrespective of their IncA ST (9). For the
present study, we report the incA sequence polymorphisms,
expression patterns of IncA, and the fusogenic properties of 98
C. trachomatis isolates from Dutch female patients. The rela-
tionship between IncA ST and the clinical outcome of infection
was also evaluated.
Females (age range, 14 to 33 years; median, 22 years), vis-
iting our Public Health Laboratory, participated after signing
an informed consent. From each female two cervical swabs
were taken. One was assessed for the presence of C. tracho-
matis DNA as described previously (14). A second cervical
swab was placed in 0.4 M sucrose phosphate buffer (4SP)
medium and used for C. trachomatis culture as well as DNA
extraction. Females with coinfections with other STD-causing
microorganisms (Candida albicans, Neisseria gonorrhoeae,
Trichomonas vaginalis, and herpes simplex virus type 1 or type
2), detected by using the described techniques, were excluded
from the study (2, 13, 17). Selected females were classified as
symptomatic based upon at least one positive answer on a
questionnaire regarding their complaints, which included in-
creased discharge, having bloody discharge during and/or after
coitus, abdominal pain, and/or dysuria. The first 98 consecu-
tively enrolled C. trachomatis-positive females without coinfec-
tion were included.
Of these females, 43 showed symptoms of infection (44%).
Two-tailed chi-square tests or Fisher’s exact test was used to
compare groups. A P value of 0.05 was considered statisti-
cally significant (SPSS Inc., Chicago, Ill.). The 4SP-collected
clinical sample was used to culture C. trachomatis in HeLa 229
cells (ATCC CCL2). Cultures were harvested and stored as
described elsewhere (7, 8). DNA for incA amplification was
extracted from the 4SP-collected clinical sample (7). incA was
amplified by thermocycling and sequenced as described previ-
ously (9). Sequence analysis (Staden Package v4.7 [www.mrc-
lmb.cam.ac.uk/pubseq/]) revealed that 96 females were in-
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fected with a C. trachomatis strain harboring an incA gene
encoding a putative full-length protein. Among the 96 IncA
sequences, nine STs were observed. Four STs represented 94%
of the strains, indicating that incA variation is limited (Fig. 1).
These four predominant types are ST1 (identical to the pro-
totypic sequence) (27%), ST2 (I47T) (36%), ST3 (I47T and
E116K) (26%), and ST4 (I218T) (5%), respectively (Table 1).
The ratio of ST1 to ST3 among the 96 isolates was 88%,
supporting previous data of a study of a collection of 25 ref-
erence laboratory strains. The ratio of ST1 to ST3 among these
strains was 64% (9). ST4 has also been described previously
(12), but ST5 to ST9 represent novel incA alleles (Table 1).
These data, in combination with the incA sequences already
deposited in GenBank, bring the total number of reported STs
to 19. Silent mutations were only observed in incA of two
strains with an ST3 IncA (not shown). Two females (2%) were
infected with C. trachomatis harboring an incA gene with a
mutation leading to a premature stop codon. The incA gene,
amplified using DNA extracted from the cotton swab specimen
of subject 46, had a single-nucleotide insertion at position 175,
leading to a frame shift and a premature stop codon at position
265. In addition, the incA amplified using DNA extracted from
the cotton swab specimen of subject 64 had a 20-bp nucleotide
duplication at position 54, leading to a frame shift and a pre-
mature stop codon at position 142. We next assessed inclusion
morphology and IncA expression by fluorescence microscopy
of infected cells using anti-major outer membrane protein
(Chlamydia direct IF identification kit; bioMe´rieux, sa Marcy
l’Etoile, France) and anti-IncA (10). HeLa 229 cells cultured
on coverslips were infected with each of the isolates at a mul-
tiplicity of infection of 5 to 10. Inclusion morphology and IncA
expression were independently judged by two persons blinded
for the code of the isolates.
Repropagation was successful with 88 of the 98 isolates. Of
88 isolates, 86 resulted in one large single bacterium containing
inclusion in infected HeLa cells observed by immunofluores-
cence using anti-MOMP (Fig. 1A). Of these 86 isolates, ex-
pression of IncA and its localization to the IM of the inclusion
was revealed by bright fluorescent labeling of the IM of the
infected cells, using anti-IncA (not shown). Chlamydia isolates
of two females resulted in a completely different inclusion
morphology after infection of HeLa cells (Fig. 1B and C).
These isolates were phenotypically characterized by the forma-
tion and persistence of multiple inclusions per infected cell,
indicating nonfusogenicity. Apparently, these multiple inclu-
sions lack IncA, as fluorescence was absent in the infected
HeLa cells when anti-IncA was used in fluorescence micros-
copy (not shown). The nonfusogenic phenotype and absence of
IncA expression was observed during several serial passages of
both isolates in HeLa cells, indicating these isolates had a
stable phenotype. Decoding of the identity of the isolates re-
vealed that the nonfusogenic isolates, lacking IncA expression,
corresponded to the two isolates carrying incA genes with an
insertion leading to a premature stop codon.
We demonstrated that 2% (2 of 88) of the isolates studied
FIG. 1. Fluorescence microscopic analyses of HeLa cells infected with clinical isolates (multiplicity of infection, 5 to 10) containing an incA gene
encoding full-length IncA (A) or an incA gene with insertions, leading to premature stop codons (B, C). Immunostaining with anti-MOMP revealed
a single inclusion in HeLa cells infected with C. trachomatis isolates (n  86), containing full-length IncA, irrespective of its ST. In contrast,
multiple small inclusions were observed in HeLa cells infected with strain 190-163-02 (B) or strain 190-059-03 (C) carrying an incA with a
premature stop codon. Bar, 10 m.
TABLE 1. C. trachomatis IncA amino acid sequence types and the
distribution among symptomatic and asymptomatic females
STa Accessionno.b
Polymorphic amino
acid sitesc
No. of females:
PdSymptomatic
(n  43)
(%)
Asymptomatic
(n  53) (%)
1 AY683465 MKIPQENT 11 (26) 15 (28) NS
2 AF683466 ..T..... 12 (28) 23 (43) NS
3 AF683467 ..T..K.. 14 (33) 10 (19) NS
4 AF683468 .......I 2 (5) 3 (6) ND
5 AF683469 L.T..... 1 (2) 1 (2) ND
6 AF683470 ..T...S. 1 (2) ND
7 AF683471 ...L.... 1 (2) ND
8 AF683472 ....E... 1 (2) ND
9 AF683473 .R.....I 1 (2) ND
a The prototype amino acid sequence IncA deduced from the DNA sequence
of strain D/UW-3/Cx is indicated as ST1 (15). ST1, ST2, and ST3 were previously
annotated as STa, STb, and STc, respectively (9).
b The GenBank accession number of the incA sequence, representative for a
ST. The sequences of two strains with insertions in incA, resulting in premature
stop codons, are not presented in the table but are available at GenBank through
accession no. AY683474 (strain 190-163-02) and AY683475 (strain 190-059-03).
c Polymorphic amino acid sites of IncA at positions 29 (M), 33 (K), 47 (I), 63
(P), 64 (Q), 116 (E), 161 (N), and 218 (T), respectively. Numbering according to
the amino acid numbering of the prototype IncA sequence (15). A dot indicates
amino acid identity with ST1.
d P values (two-tailed) are based on chi-square analysis. NS, not significant;
ND, not determined.
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were nonfusogenic, consistent with the results of Suchland and
coworkers from the United States (16), indicating that in The
Netherlands nonfusogenicity of C. trachomatis isolates as seen
in the United States is a rare phenomenon. The two nonfuso-
genic strains described in our study were isolated from symp-
tomatic female patients. Geisler and colleagues have reported
that females infected with nonfusogenic strains had fewer signs
and symptoms of infections than females infected with fuso-
genic strains (3, 16). In our study population, it was impossible
to predict whether the presence or absence of IncA may lead
to differences in the course of infection, due to the low pro-
portion of nonfusogenic strains. In addition, association be-
tween IncA ST and disease was also absent. Chlamydial iso-
lates harboring ST1, ST2, or ST3, the prevalent IncA STs
among chlamydial isolates of our study population, were ran-
domly distributed among the symptomatic and asymptomatic
patients (Table 1). Moreover, a relationship between ST1, ST2,
or ST3 and individual symptoms or a combination of symptoms
was not found. We conclude that, in this study population,
IncA ST variation is limited and that ST1 to ST3 are not
related to clinical manifestations of a C. trachomatis infection.
Nucleotide sequence accession numbers. The nucleotide se-
quences of incA, representative of ST1 to ST9, and the se-
quences of incA with a premature stop codon are deposited in
the GenBank under the accession numbers indicated in the
Table 1.
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